Optimal dilution to be determined by the researcher.
Specificity and Use
S100A1 / S100 antibody was raised against peptide derived from C-terminal sequence of human S100-A1 protein.
C-Terminus
Immunohistochemistry: LS-B2667 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B2667 was determined to be 10 ug/ml.
S100A1 Antibody, S100 alpha Antibody, S100-alpha Antibody, Protein S100-A1 Antibody, S-100 protein alpha chain Antibody, S100 Antibody, S-100 protein subunit alpha Antibody, S100A Antibody
S100A1 has been suggested to be a regulator of myocardial contractility. S100A1 improves cardiac contractile performance both by regulating sarcoplasmic reticulum calcium ion handling and myofibrillar calcium ion responsiveness. S100 is an astrocyte marker.
PDF Spec Sheet
Technical Help
